Nine Monthly Results Results Snapshot
Figures in Cr
Consolidate Nine Monthly Results
Dec'25
Net Sales
200.81
Other Operating Income
0.00
Total Operating income
200.81
Raw Material Cost
16.82
Purchase of Finished goods
85.45
(Increase) / Decrease In Stocks
-3.32
Employee Cost
31.30
Power Cost
0.00
Manufacturing Expenses
-0.01
Selling and Distribution Expenses
0.00
Other Expenses
30.44
Total Expenditure (Excl Depreciation)
160.68
Operating Profit (PBDIT) excl Other Income
40.13
Other Income
2.46
Operating Profit (PBDIT)
42.59
Interest
4.08
Exceptional Items
-2.23
Gross Profit (PBDT)
36.28
Depreciation
7.33
Profit Before Tax
28.95
Tax
7.41
Provisions and contingencies
0.00
Profit After Tax
21.54
Extraordinary Items
0.00
Prior Period Expenses
0.00
Other Adjustments
0.00
Net Profit
21.54
Share in Profit of Associates
-0.49
Minority Interest
-0.91
Other related items
0.00
Consolidated Net Profit
20.14
Equity Capital
20.00
Face Value
10.0
Reserves
0.00
Diluted Earnings per share
1.86
Operating Profit Margin (Excl OI)
19.98%
Gross Profit Margin
18.07%
PAT Margin
10.73%
Public Share Holdings (%)
0.0%
Pledged Promotor Holding (%)
0.0%
Nine Monthly Analysis Highlights
Net Sales
YoY Growth in nine months ended Dec 2025 is 14.51%
Standalone Net Profit
YoY Growth in nine months ended Dec 2025 is 32.95%
Operating Profit (PBDIT) excl Other Income
YoY Growth in nine months ended Dec 2025 is 26.87%
Interest
YoY Growth in nine months ended Dec 2025 is 15.47%
Operating Profit Margin (Excl OI)
YoY Growth in nine months ended Dec 2025 has improved from Dec 2025
Compare Nine Monthly Results Of Chandan Healthca With
Figures in Cr
Consolidate Nine Monthly Results
Change(INR)
Change(%)
Net Sales
200.81
0
200.81
Other Operating Income
0.00
0.00
0.00
Total Operating income
200.81
0
200.81
Raw Material Cost
16.82
0
16.82
Purchase of Finished goods
85.45
0
85.45
(Increase) / Decrease In Stocks
-3.32
0
-3.32
Employee Cost
31.30
0
31.30
Power Cost
0.00
0
0.00
Manufacturing Expenses
-0.01
0
-0.01
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
30.44
0.00
30.44
Total Expenditure (Excl Depreciation)
160.68
0
160.68
Operating Profit (PBDIT) excl Other Income
40.13
0.00
40.13
Other Income
2.46
0
2.46
Operating Profit (PBDIT)
42.59
0
42.59
Interest
4.08
0
4.08
Exceptional Items
-2.23
0
-2.23
Gross Profit (PBDT)
36.28
0
36.28
Depreciation
7.33
0
7.33
Profit Before Tax
28.95
0
28.95
Tax
7.41
0
7.41
Provisions and contingencies
0.00
0
0.00
Profit After Tax
21.54
0
21.54
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
21.54
0
21.54
Share in Profit of Associates
-0.49
0
-0.49
Minority Interest
-0.91
0
-0.91
Other related items
0.00
0.00
0.00
Consolidated Net Profit
20.14
0
20.14
Equity Capital
20.00
0
20.00
Face Value
10.00
0
0.00
Reserves
0.00
0
0.00
Gross Profit Margin
18.07%
0%
0.00
18.07%
PAT Margin
10.73%
0%
0.00
10.73%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 111.88 Cr
in Dec 2025Figures in Cr
Nine Monthly - Standalone Net Profit
Standalone Net Profit 18.52 Cr
in Dec 2025Figures in Cr
Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 35.13 Cr
in Dec 2025Figures in Cr
Nine Monthly - Interest
Interest 3.06 Cr
in Dec 2025Figures in Cr
Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 31.40%
in Dec 2025Figures in %
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
